TPST - Tempest Therapeutics, Inc.
6.42
-0.250 -3.894%
Share volume: 39,290
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$6.67
-0.25
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 7.974 M | 9.582 M | 10.551 M | 13.919 M | |
| Selling general and admin | 3.634 M | 3.745 M | 2.994 M | 3.177 M | |
| Research and development | 4.340 M | 5.837 M | 7.557 M | 10.742 M | |
| Total expenses | 7.974 M | 9.582 M | 10.551 M | 13.919 M | |
| 20.17% | 10.11% | 31.92% | |||
| Operating income | -7.974 M | -9.582 M | -10.551 M | -13.919 M | |
| Ebit | -7.536 M | -9.198 M | -10.227 M | -13.566 M | |
| Pretax income | -7.904 M | -9.570 M | -10.556 M | -13.813 M | |
| 21.08% | 10.30% | 30.85% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.904 M | -9.570 M | -10.556 M | -13.813 M | |
| -21.08% | -10.30% | -30.85% |
